Ryan J. Dillon, MSc

Director, Global Pharmaceuticals
Merck & Co., Inc

Disclosure(s): Merck: Employee, Stocks/Bonds

My name is Ryan Dillon, BSc, MSc. I am an Associate Dircector working within CORE (Center for Observational and Real-World Evidence) at Merck & Co. Inc. Within my role I am responsible for the generation and dissemination of Real-World evidene in support of the antimicrobial portfolio. My areas of focus include systematic literature review, network meta-analysis, and other forms observational research.

Poster(s):

• 653 - Characterizing Antibacterial Regimen Modification, Patient Characteristics, and Outcomes for Patients with Complicated Gram-negative Bacterial Infections
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 663 - Incidence of Acute Kidney Injury (AKI) among Adult Hospitalized Patients (pts) with Carbapenem Resistant Gram-Negative Infections (CR-GNIs) Who Received Early Targeted Treatment (TX) with a Newer β-Lactam (BL)-, Colistin (COL)-, or Aminoglycoside (AG)-Containing Regimen
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET